02/09/2009
ReGen Therapeutics Plc (“ReGen” or the “Company”), (AIM:RGT) is pleased to announce that it has conditionally placed 3,000,000 new ordinary shares at 4p per ordinary share to raise £120,000 before expenses for general working capital purposes.
The 3,000,000 new ordinary shares, which will represent 8.76 per cent of the enlarged issued share capital of the Company (in aggregate amounting to 34,229,882 ordinary shares on completion of the placing), will rank pari passu in all respects with the existing ordinary shares in the Company.
Percy Lomax Chairman and Chief Executive commented:
‘So far this year ReGen has raised £613,185. We note that the placing is at a share price a third higher than at the last placing and believe this reflects investor confidence in the Company.
Application has been made to the London Stock Exchange for the new ordinary shares to be admitted to trading on AIM and admission is expected to commence on or around 8 September 2009.
For further information, please contact:
Percy Lomax
ReGen Therapeutics Plc
Tel: 020 7153 4920
Roland Cornish/Felicity Geidt
Beaumont Cornish Limited
Tel: 020 7628 3396